Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma

Toll-like receptor 9 (TLR9) is a cellular DNA-receptor of the innate immune system that is widely expressed in cancers. We demonstrated that low tumor TLR9 expression predicts poor disease-specific survival in triple negative breast cancer (TNBC) and renal cell carcinoma (RCC). We hypothesized that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Mella, Mikko, Kauppila, Joonas H, Karihtala, Peeter, Lehenkari, Petri, Jukkola-Vuorinen, Arja, Soini, Ylermi, Auvinen, Päivi, Vaarala, Markku H, Ronkainen, Hanna, Kauppila, Saila, Haapasaari, Kirsi-Maria, Vuopala, Katri S, Selander, Katri S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485740/
https://ncbi.nlm.nih.gov/pubmed/26155410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2014.1002726
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller